Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians-Reference-Cited by-同舟云学术

Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians

Published:2021-08 Issue:8 Volume:134 Page:939-942
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Terrier Jean^ORCID,Gaspar Frédéric,Fontana Pierre,Daali Youssef,Reny Jean-Luc,Csajka Chantal,Samer Caroline F.

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. European Society of Cardiology. Guidelines for management of atrial fibrillation. Available at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management. Accessed April 6, 2021.

2. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

3. Measuring non-vitamin K antagonist oral anticoagulant levels: when is it appropriate and which methods should be used?;Drouet;Int J Stroke,2016

4. Direct oral anticoagulant use: a practical guide to common clinical challenges;Chen;J Am Heart Assoc,2020

5. European Medicine Agency. Dabigatran, rivaroxaban, apixaban and edoxaban product information. Available at: https://www.ema.europa.eu/en/glossary/product-information. Accessed April 6, 2021.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland;Frontiers in Pharmacology;2024-04-02

2. In vitro-in silico pharmacology and chemistry of Stercularin, isolated from Sterculia diversifolia;Computational Biology and Chemistry;2024-04

3. Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy;Clinical Pharmacokinetics;2024-03

4. Population pharmacokinetics of apixaban in a real‐life hospitalized population from the OptimAT study;CPT: Pharmacometrics & Systems Pharmacology;2023-09-18

5. Direct oral anticoagulant drugs for the management of venous thromboembolism;The Nurse Practitioner;2023-06